Researchers report the 'love hormone', oxytocin, could enhance the pleasure of social interactions be stimulating the production of anandamide.
Researchers discover the FABP5 protein is key to how endocannibinoids travel from neurons to receptors.
Researchers discover THC and CBD prevent inflammation in the spinal cord and brain of mice with MS-like symptoms.
An imbalance in gut bacteria can cause the reduction of some metabolites, resulting in depression-like symptoms. The findings contribute to the growing body of evidence for the role the microbiome plays in brain function and mental health.
The findings could provide new insights into brain diseases such as Alzheimer's, schizophrenia and depression.
Amyloid beta has been implicated in blocking endocannabinoids in the hippocampus; impairing learning and memory long before Alzheimer's plaques form in the brain.
Anandamide, an endogenous compound produced in the body, plays a role in reversing memories of traumatic events. The findings could lead to new treatments for PTSD.
A rare genetic mutation has been associated with pain insensitivity. The findings could further research into new treatments to target pain.
A new study reports on how endocannabinoids are affected by sleep deprivation and whether exercise can modulate the effect.
GABA accelerates the breakdown of endocannabinoids in the brain. Endocannabinoids are critical for emotional processing. The findings could lead to the development of new treatments for emotional behavioral disorders.
Researchers have discovered biological differences between males and females in the molecular regulation of synapses in the hippocampus.
While endocannabinoids have been reported to play a role in anti-inflammation in some areas of the brain, a new study reveals they may cause inflammation in the cerebellum.